CONTACTStaffCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2024 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
The sexually transmitted disease gonorrhea is now among the ''superbugs" resistant to common antibiotics, leading U.S. health officials to recommend wider use of a different class of drugs to avert a public-health crisis.
The resistant form accounts for more than one in every four gonorrhea cases among heterosexual men in Philadelphia and nearly that many in San Francisco, according to a survey that led to Thursday's recommendation by the Centers for Disease Control and Prevention.
Gonorrhea, which is believed to infect more than 700,000 people in the United States each year, can leave both men and women infertile and puts people at higher risk of getting the AIDS virus.
Since the early 1990s a class of drugs known as fluoroquinolones has provided a relatively easy cure. These antibiotics, taken as tablets, include the drug Cipro.
But a growing number of gonorrhea cases is resistant to those drugs, and officials at the CDC for the first time are urging doctors to stop using fluoroquinolones and switch to cephalosporins, a different class of antibiotics, to treat everyone.
Those drugs--which include the generic ceftriaxone, or brand name Rocephin, made by Swiss drugmaker Roche Holding AG--must be given as a shot and aren't as readily stocked as Cipro on most doctor's shelves.
''Gonorrhea has now joined the list of other superbugs for which treatment options have become dangerously few,'' said Henry Masur, president of the Infectious Diseases Society of America. ''To make a bad problem even worse, we're also seeing a decline in the development of new antibiotics to treat these infections.''
The CDC made the new recommendation after discovering that nearly 7% of gonorrhea cases among heterosexual men in a survey of 26 U.S. cities last year were drug-resistant. In 2001 only about 0.6% of gonorrhea cases among heterosexual men were drug-resistant.
''That leaves us with a single class of highly effective antibiotics,'' said John Douglas Jr., director of the CDC's division of STD prevention. Other experts called the situation perilous.
''We are running out of options to treat this disease,'' added Douglas, who said there are ''no new drugs for gonorrhea in the drug development pipeline.''
Previously, CDC recommended against fluoroquinolones to treat drug-resistant gonorrhea among men who have sex with men and in certain states, including California and Hawaii, where most of these cases were turning up.
Described by Douglas as a ''very wily'' disease, gonorrhea has worked its way through decades of other treatment regimens, from sulfa drugs used in the 1930s and 1940s, to penicillin, which was used from the 1940s until the mid 1980s.
Gonorrhea, spread through sexual contact, is the second most commonly reported infectious disease in the United States, trailing only chlamydia, which the CDC says affects more than 2.1 million people yearly in the U.S.
The highest rates of infection are among sexually active teens, young adults, and African-Americans. Because many people don't have obvious symptoms, they can unknowingly spread it to others. And having it makes people more susceptible to HIV. Gonorrhea's spread is preventable through consistent and proper use of condoms, experts said.
In women the infection can cause pelvic inflammatory disease. In men it can cause epididymitis, a painful condition of the testicles that can lead to infertility if untreated, the CDC said.
In the survey of gonorrhea cases among heterosexual men in 26 cities last year, Philadelphia had the highest percentage of drug-resistant cases with almost 27%, a dramatic increase from only 1.2% in 2004.
San Francisco's drug-resistant cases more than doubled between 2004 and 2006, from 10.3% to 22.5%. During the same period Miami's cases spiked from 2.1% to 15.3% and Atlanta's climbed from 1% to 5.7%. (AP)
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Here Are Our 2024 Election Predictions. Will They Come True?
November 07 2023 1:46 PM
Meet all 37 of the queer women in this season's WNBA
April 17 2024 11:24 AM
17 Celebs Who Are Out & Proud of Their Trans & Nonbinary Kids
November 30 2023 10:41 AM
Here Are the 15 Most LGBTQ-Friendly Cities in the U.S.
November 01 2023 5:09 PM
Which State Is the Queerest? These Are the States With the Most LGBTQ+ People
December 11 2023 10:00 AM
These 27 Senate Hearing Room Gay Sex Jokes Are Truly Exquisite
December 17 2023 3:33 PM
10 Cheeky and Homoerotic Photos From Bob Mizer's Nude Films
November 18 2023 10:05 PM
42 Flaming Hot Photos From 2024's Australian Firefighters Calendar
November 10 2023 6:08 PM
These Are the 5 States With the Smallest Percentage of LGBTQ+ People
December 13 2023 9:15 AM
Here are the 15 gayest travel destinations in the world: report
March 26 2024 9:23 AM
Watch Now: The Daily
Trending stories from our video partner Advocate Channel.
For more videos and shows go to advocatechannel.com.
Trending stories from our video partner Advocate Channel.
For more videos and shows go to advocatechannel.com.
Latest Stories
Serial killer of gay men in New Orleans released after 46 years in prison
April 24 2024 2:16 PM
The 'largest bi+ event in the world' is happening this year. Here's when and where
April 24 2024 12:42 PM
What happens if Donald Trump is jailed for criminal contempt?
April 24 2024 12:22 PM
Megan Rapinoe, Sue Bird, and more urge NCAA to stand up for trans inclusion
April 24 2024 8:00 AM
Over 90% of trans youth live in states pushing anti-trans legislation: report
April 23 2024 10:08 PM
George Santos pulls out of New York congressional race
April 23 2024 7:04 PM